Background illustration for clinical trials search

Paid Clinical Trials St. Louis

Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,378

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

for

Pulmonary Arterial Hypertension

Location: St Louis MO, Kansas City KS, Louisville KY,

Sponsor: Inhibikase Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07365332

Phase3, Recruiting

Motixafortide for MRD Sensitization in AML

for

Acute Myeloid Leukemia, Measurable Residual Disease

Location: St Louis MO

Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07392970

Phase2, Recruiting

Low-Count Quantitative SPECT for Men Treated With Radium-223

for

Prostate Cancer, Cancer of the Prostate

Location: St Louis MO

Sponsor: Washington University School of Medicine

Sex: Male

Age: 18+

Code: NCT07221825

Recruiting

Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging

for

Cystic Fibrosis

Location: Saint Louis MO

Sponsor: National Center for Research Resources (NCRR)

Sex: Female

Age: 18+

Code: NCT00023465

Recruiting

Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

for

Pre-Bronchiolitis Obliterans Syndrome

Location: St Louis MO, Iowa City IA, Maywood IL, Columbus OH,

Sponsor: Renovion, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05654922

Phase3, Recruiting

Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair

for

Hand Transplantation, Peripheral Nerve Injuries,

Location: Saint Louis MO, Columbia MO, Louisville KY

Sponsor: University of Missouri-Columbia

Sex: All

Age: 18+

Code: NCT03610763

Recruiting

Comparison of Daily Nocturnal Hemodialysis With Daily Hemodialysis

for

Kidney Failure, Chronic

Location: St. Louis MO

Sponsor: National Center for Research Resources (NCRR)

Sex: All

Age: 21 - 70+

Code: NCT00012441

Recruiting

Gas Exchange for Predicting Hospital Heart Failure Readmissions

for

Acute Decompensated Heart Failure

Location: St. Louis MO, Edina MN, Minneapolis MN, Cleveland OH,

Sponsor: Shape Medical Systems, Inc.

Sex: All

Age: 18+

Code: NCT01960218

Recruiting

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

for

Anatomic Stage III Breast Cancer AJCC v8,

Location: St Louis MO, Boston MA

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07137416

Phase1, Recruiting

New

ENGAGE-TBI Feasibility Study

for

TBI (Traumatic Brain Injury)

Location: St Louis MO

Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07549997

Phase1, Recruiting

New

Feasibility of SUPPORT-TBI

for

TBI Traumatic Brain Injury

Location: St Louis MO

Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07625098

Phase1, Recruiting

New

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

for

Small Cell Lung Cancer (SCLC ),

Location: St Louis MO, Nashville TN, Dallas TX, Houston TX,

Sponsor: Moonlight Bio, Inc

Sex: All

Age: 18+

Code: NCT07488923

Phase1, Recruiting

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

for

Metabolic Dysfunction-associated Steatohepatitis

Location: St Louis MO, Columbia MO, Little Rock AR, South Bend IN,

Sponsor: Eccogene

Sex: All

Age: 18 - 70+

Code: NCT07288138

Phase2, Recruiting

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

for

Breast Cancer, Metastatic

Location: St Louis MO, Zion IL, Omaha NE, Ann Arbor MI,

Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07007559

Phase2, Recruiting

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for

Chronic Inflammatory Demyelinating Polyneuropathy

Location: St Louis MO, Kansas City KS, Glenview IL, Cincinnati OH,

Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06290141

Phase3, Recruiting

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

for

Ulcerative Colitis

Location: St Louis MO, Iowa City IA, Wyoming MI, Marietta GA,

Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT06975722

Phase2, Recruiting

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

for

Crohn's Disease

Location: St Louis MO, Iowa City IA, Kansas City KS, Wyoming MI,

Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT06958536

Phase2, Recruiting

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

for

Chronic Lymphocytic Leukemia

Location: St. Louis MO, Gurnee IL, Branson MO, Lafayette IN,

Sponsor: East Valley Hematology and Oncology Medical Group

Sex: All

Age: 18+

Code: NCT00131313

Recruiting

Active & Responsive

A Study of YL201 in Patients With Advanced Solid Tumors

for

Advanced Solid Tumor

Location: St Louis MO, Nashville TN, Ann Arbor MI, Detroit MI,

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05434234

Phase1, Phase2, Recruiting

Featured

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

for

Hepatocellular Carcinoma

Location: St Louis MO, Louisville KY, Chicago IL, Detroit MI,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06109272

Phase2, Phase3, Recruiting

Paid Clinical Trials St. Louis

Filter results

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

Motixafortide for MRD Sensitization in AML

Low-Count Quantitative SPECT for Men Treated With Radium-223

Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging

Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

Interested in new trials?

Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair

Comparison of Daily Nocturnal Hemodialysis With Daily Hemodialysis

Gas Exchange for Predicting Hospital Heart Failure Readmissions

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

ENGAGE-TBI Feasibility Study

Feasibility of SUPPORT-TBI

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

A Study of YL201 in Patients With Advanced Solid Tumors

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)